O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Cerebellar Hypoplasia (CHP) in Eurasier dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. By using a reliable DNA test, Eurasier owners can ensure healthier litters and improve overall breed health. Understanding the genetic risks of CHP allows for informed breeding decisions and better management of affected dogs. Regular screening is essential for maintaining the Eurasier’s quality of life and vitality. Invest in a DNA test for Cerebellar Hypoplasia to protect your Eurasier’s future. Stay proactive in safeguarding your dog’s health with advanced genetic testing.
The DNA test for Cerebellar Hypoplasia in Eurasier (CHP) helps identify carriers of this genetic disorder. CHP affects the development of the cerebellum, leading to coordination and balance issues in affected dogs. By testing, breeders can make informed decisions to avoid producing affected puppies. Early detection through DNA testing promotes healthier breeding practices within the Eurasier community. This test is a valuable tool for maintaining the breed’s overall health and well-being.
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Cerebellar Hypoplasia (CHP) is a neurological condition characterized by the underdevelopment of the cerebellum, a part of the brain responsible for coordinating movement and balance. In Eurasier dogs, this genetic disorder can lead to a range of motor difficulties, affecting their ability to walk, run, and perform other physical activities. Symptoms often manifest early in a dog’s life, typically within the first few months, and can vary in severity from mild to profound impairment.
The condition is caused by specific genetic mutations that disrupt normal cerebellar development. These mutations can be identified through DNA testing, which allows breeders and owners to determine the genetic predisposition of their dogs towards CHP. Understanding the genetic basis of this condition is crucial for responsible breeding practices, as it helps reduce the risk of passing on the disorder to future generations.
Dogs with Cerebellar Hypoplasia may exhibit a range of symptoms that can include uncoordinated movements, difficulty maintaining balance, and an abnormal gait. Some affected dogs may also display tremors or exhibit a wide stance when walking. Diagnosis typically involves a combination of clinical examination and genetic testing to confirm the presence of mutations associated with the condition. It is essential for owners to consult with a veterinarian if they suspect their dog may be affected, as early diagnosis can aid in managing the symptoms effectively.
While there is currently no cure for Cerebellar Hypoplasia, various management strategies can help improve the quality of life for affected dogs. These may include physical therapy, which can enhance muscle strength and coordination, and environmental modifications to create a safe living space. Providing a supportive and loving environment is crucial, as dogs with CHP can lead fulfilling lives despite their challenges.
DNA testing plays a vital role in breeding programs aimed at minimizing the incidence of Cerebellar Hypoplasia in Eurasier dogs. By identifying carriers of the genetic mutations linked to this condition, breeders can make informed decisions to avoid breeding practices that may perpetuate the disorder. This proactive approach not only helps maintain the health of the breed but also promotes overall responsible breeding ethics.
Cerebellar Hypoplasia in Eurasier dogs is a serious genetic condition that impacts their neurological function and quality of life. Through understanding the genetic basis, symptoms, and management of CHP, owners and breeders can work together to address this disorder. DNA testing serves as a critical tool in identifying at-risk animals and fostering healthier breeding practices, ultimately leading to a stronger and more resilient breed.
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
This DNA test detects the mutation associated with Cerebellar Hypoplasia In Eurasier (CHP-E) in order to identify clear, carrier, or at-risk animals.
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
O modo de herança relatado para este teste é Autossômico Recessivo.
This test analyses the mutation VLDLR c.1713delC.
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Gerber Martina, Fischer Andrea, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord, Schmidt Martin J, Bernardino Filipa, Manz Eberhard, Matiasek Kaspar, Rentmeister Kai, Leeb Tosso. A deletion in the VLDLR gene in Eurasier dogs with cerebellar hypoplasia resembling a Dandy-Walker-like malformation (DWLM). PLoS One. 2015 Feb 10;10(2):e0108917. doi: 10.1371/journal.pone.0108917. eCollection 2015.
Sua privacidade, sua escolha
Usamos cookies essenciais para operar o site. Cookies opcionais (como provedores de conteúdo incorporados) estão desabilitados por padrão e só são habilitados se você concordar. Você pode alterar sua escolha a qualquer momento através do botão “Cookies”.
Necessário para recursos básicos e segurança. Sempre habilitado.
Melhora recursos como salvamento de preferências ou incorporações não publicitárias.
Ajuda-nos a entender o uso do site. Desativado por padrão.
Publicidade/rastreamento em sites (algumas incorporações de vídeos/mapas). Desativado por padrão.